Shareholders meeting

17th July, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (East), M umbai- 400 001 Mumbai - 400 051 Scrip Code: 500259 S crip Code: LYKALABS Dear Sir, Sub: Notice of the 47th Annual General Meeting (the AGM) of the Company for FY 2025-26 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is the Notice along with the Explanatory Statement of the 47th AGM of the Company scheduled to be held on Monday, the 10th August 2026 at 12:30 p.m. (IST) through Video Conferencing (VC) / Other Audio-Visual Means. The said Notice forms part of the Annual Report 2025-26 which is being sent through electronic mode to the Members. The Annual Report containing the Notice of the AGM is also available on the website of the Company at www.lykalabs.com This is for your information and records. Thanking you, Yours faithfully, For Lyka Labs Limited Shailendra Kumar Agrawal Company Secretary and Compliance Officer Encl.: as above Lyka Labs Limited NOTICE is hereby given that 47th Annual General Meeting (the AGM) of the Members of Lyka Labs Limited will be held on Monday, the 10th August, 2026 at 12: 30 P.M. through Video Conferencing (VC)/ Other Audio Visual Means (OVAM) to transact the following businesses: ORDINARY BUSINESS: 1. Adoption of Audited Financial Statements and Reports thereon: a. the Audited Financial Statements of the Company for the financial year ended on 31st March, 2026 together with the Reports of the Board of Directors and Auditors thereon; and b. the Audited Consolidated Financial Statements of the Company for the financial year ended on 31st March, 2026 together with the Report of the Auditors thereon. 2. Appointment of Director in place of those retiring by rotation To appoint a Director in place of Mr. Shashil Philip Mendonsa, (DIN: 09667654) who retires by rotation and being eligible, offers himself for re-appointment. SPECIAL BUSINESS: 3. Ratification of Remuneration of Cost Auditor for FY 2025-2026 To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148(3) and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 14 Rule 14 of Companies (Audit and Auditors) Rules, 2014 including any statutory modification(s) or re-enactment(s) thereof, for the time being in force and based on the recommendation of the Audit Committee and the approval of the Board of Directors of the Company, the remuneration payable to Messrs Nidhi Subhash Tibrewala & Co., Cost Accountants (Firm Registration No: 005417), appointed by the Board of Directors of the Company as the Cost Auditors to conduct the audit of the cost accounting records of the Company for the financial year ending 31st March, 2026, amounting to Rs. 1,60,000/- (Rupees One Lakh Sixty Thousand Only) plus applicable taxes and reimbursement of out-of-pocket expenses, in connection with the said audit, be and is hereby ratified and confirmed; RESOLVED FURTHER THAT for the purpose of giving effect to this resolution, the Board of Directors and Key Managerial Personnel be and is hereby authorised to do all such acts, deeds, matters and things as it may, in its absolute discretion deemed necessary, proper or desirable and to settle any questions, difficulties and/or doubts that may arise in this regard in order to implement and give effect to the foregoing resolution.” 4. Ratification of Remuneration of Cost Auditor for FY 2026-27 To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148(3) and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 14 Rule 14 of Companies (Audit and Auditors) Rules, 2014 including any statutory modification(s) or re-enactment(s) thereof, for the time being in force and based on the recommendation of the Audit Committee and the approval of the Board of Directors of the Company, the remuneration payable to Messrs Nidhi Subhash Tibrewala & Co., Cost Accountants (Firm Registration No: 005417), appointed by the Board of Directors of the Company as the Cost Auditors to conduct the audit of the cost accounting records of the Company for the financial year ending 31st March, 2027, amounting to Rs. 1,60,000/- (Rupees One Lakh Sixty Thousand Only) plus applicable taxes and reimbursement of out-of-pocket expenses, in connection with the said audit, be and is hereby ratified and confirmed; RESOLVED FURTHER THAT for the purpose of giving effect to this resolution, the Board of Directors be and is hereby authorised to do all such acts, deeds, matters and things as it may, in its absolute discretion deemed necessary, proper or desirable and to settle any questions, difficulties and/or doubts that may arise in this regard in order to implement and give effect to the foregoing resolution.” 5. Approval of Material Related Party Transactions with IPCA Laboratories Limited for the Financial Year 2026-27 To consider and, if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to provisions of Section 188 of the Companies Act, 2013 (“Act”) read with the Rules made thereunder, Regulation 23 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), the applicable SEBI Circulars issued from time to time, including the Industry Standards on ‘Minimum Information to be provided for Review of the Audit Committee and Shareholders for Approval of Related Party Transactions’, Secretarial Standard-2 issued by the Institute of Company Secretaries of India, the Company’s Policy on Materiality of Related Party Transactions and on Dealing with Related Party Transactions and subject to such statutory, regulatory and other approvals, consents, permissions and sanctions as may be necessary, and pursuant to the prior approval of the Audit Committee and recommendation of the Board of Directors of the Company, approval of the Members be and is hereby accorded to enter into and/or continue to enter into one or more contract(s), arrangement(s) and/or transaction(s) (whether by way of an individual transaction or transactions taken together or a series of transactions), including any renewal(s), continuation(s), modification(s) or extension(s) thereof, with IPCA Laboratories Limited (“IPCA”), a Promoter of the Company and a Related Party within the meaning of the Act and the SEBI Listing Regulations, during the Financial Year 2026-27, for an aggregate value not exceeding ₹75,00,00,000 (Rupees Seventy Five Crores only), on such terms and conditions as may be mutually agreed between the parties, in connection with any one or more of the following transactions: a. sale, purchase or supply of raw materials, APIs, finished goods, packing materials, capital goods, plant and machinery or other goods; b. contract manufacturing, loan licence manufacturing and other manufacturing arrangements; c. rendering and/or availing of services; d. sale, purchase, lease, transfer or disposal of movable assets; e. placement and acceptance of Inter-Corporate Deposits together with payment or receipt of interest thereon; f. such other operational or commercial transactions as may be necessary in the ordinary course of business; provided that all such transaction(s) shall be undertaken in the ordinary course of business, on an arm’s length basis, on commercially competitive terms and in the best interests of the Company. RESOLVED FURTHER THAT the aforesaid transaction(s) shall be subject to periodic review by the Audit Committee in accordance with the applicable provisions of the SEBI [Showing first 8,000 characters — download PDF for full document]